All Editorial articles – Page 192
-
NewsResearchers valuate the safety and efficacy of a smallpox vaccine for preventing mpox
Researchers explored the viability and safety of LC16m8, an attenuated vaccinia virus vaccine, to prevent monkeypox. The study evaluated the immunogenicity and safety of LC16m8 across three animal species.
-
NewsScientists win award for bringing breakthrough HIV treatment lenacapavir into play
Three people have been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for their work on the first HIV drug to offer long-lasting protection from infection — eliminating the need for people to take a daily pill.
-
NewsSynthetic lichen points a pathway to self-healing concrete
Addressing one of the most persistent and expensive problems in construction, scientists have taken inspiration from nature to develop a synthetic lichen system to enable concrete to self-repair.
-
NewsTransforming hospital sanitation: autonomous robots for wiping and UV-C disinfection
Scientists have developed an ’Intelligent Autonomous Wiping and UV-C Disinfection Robot’ capable of automating hospital disinfection processes. The system can perform disinfection with consistent precision, significantly reducing the risk of infection within the hospital.
-
NewsGlobal review of bird flu in cats points to risk of another pandemic
Bird flu (H5N1) is rapidly evolving into the possibility of a human pandemic, say researchers who have been documenting research on bird flu in cats and calling for urgent surveillance of cats to help avoid human-to-human transmission.
-
NewsScientists discover antibiotic resistance in newly identified bacterium
Staphylococcus borealis has been found to be resistant to several different types of antibiotics, posing a potentially significant problem for the elderly.
-
NewsFoot traffic can predict COVID-19 spread in New York City neighborhoods
A new study reveals how foot traffic data from mobile devices can enhance neighborhood-level COVID-19 forecasts in New York City, providing a novel approach to predicting the spread of the SARS-CoV-2 virus and improving targeted public health interventions.
-
NewsResearchers deploy phage enzyme to restore antibiotic effect in the event of resistance
Researchers have shown that if antibiotics are administered with an enzyme called endolysin, the combined effect protects against infection by resistant bacteria in all bodily organs – including the brain, which antibiotics alone have difficulty reaching.
-
NewsResearch collaboration takes ‘one health’ approach to study Chagas disease
Researchers have received more than $4 million from federal and non-governmental organizations to support research on Chagas disease prevalence, diagnostics and treatment to benefit both dogs and humans.
-
NewsViruses under the super microscope: How influenza viruses communicate with cells
Scientists have characterized a new model of influenza A infection: binding to MHC class II complexes as an alternative receptor and the associated dynamic reorganization of the cell surface.
-
NewsDisease experts call for reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC)
The Society for Healthcare Epidemiology of America has called for the reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), warning that decades of progress in preventing healthcare-associated infections are under threat.
-
OpinionIt’s game over for dangerous Gain of Function research
The Trump adminstration has signed an Executive Order halting federal gain of function research on microbes - but does it throw the baby out with the bathwater? Virologist Simon Wain-Hobson, Emeritus Professor with the Pasteur Institute, Paris, gives his take.
-
NewsSpiritual healing sites could be linked to antibiotic-producing microorganisms
A study by AMI member Dr Gerry Quinn highlights the potential of spiritual healing sites as fertile ground for novel antibiotics, particularly from Streptomyces bacteria, known for producing the majority of current antibiotics.
-
NewsBat virus evolution suggests wildlife trade sparked COVID-19 virus emergence in humans
The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years before the disease first emerged in humans up to 2,700 kilometers away in Central China, suggesting the wildlife trade played a role.
-
NewsBreakthrough discovery uses gut bacteria and AI to diagnose a chronic pain syndrome
Scientists have developed AI technology that can detect patterns in gut bacteria to identify complex regional pain syndrome (CRPS) with remarkable accuracy, potentially transforming how CRPS is diagnosed and treated.
-
NewsSilver nanoparticles produced by fungus could be used to prevent and treat COVID-19
Silver nanoparticles produced by the fungus Trichoderma reesei could become important allies in the prevention and treatment of COVID-19. Tests on hamsters showed that they not only inhibited the infection but also reduced the viral load in the lungs.
-
NewsFood as medicine: How diet shapes gut microbiome health
New research shows how mice fed a Western-style diet are not able to rebuild a ‘healthy’, diverse gut microbiome following antibiotic treatment. These mice were also more susceptible to infection by pathogens like Salmonella.
-
NewsEngineered soil microbiomes may secure future tomato yields
New findings suggest that manipulating rhizosphere microbiomes could be a sustainable strategy to enhance crop performance in fluctuating environments, supporting the development of resilient agricultural systems.
-
NewsHigh-density screening technique reveals key genes for biotechnology improvements
Scientists used a gene-silencing tool and molecular guides to probe how photosynthetic bacteria adapt to light and temperature changes, finding even partial suppression of certain genes yielded big benefits in modifying the stress response of wild microbes.
-
NewsLong COVID may cause long-term changes in the heart and lungs and may lead to cardiac and pulmonary diseases
Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection, potentially placing them at elevated risk for future cardiac and pulmonary conditions.